MORGAN STANLEY PLC/CALL/CENCORA/260/0.1/21.06.24 | Real-time Bid/Ask 17:45:31 29/05/2024 BST | ||
| 0.029 EUR / 0.062 EUR | +4,500.00% |
|
| Current month | -99.51% | ||
| 1 month | -99.60% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
CENCORA, INC.
Latest news about CENCORA, INC.
| Date | Price | Change |
|---|---|---|
| 29/05/24 | 0.028 | +2,700.00% |
| 28/05/24 | 0.001 | 0.00% |
| 27/05/24 | 0.001 | -96.67% |
| 24/05/24 | 0.03 | +1,400.00% |
| 23/05/24 | 0.002 | -94.74% |
Delayed Quote Börse Stuttgart
Last update May 29, 2024 at 04:27 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | CENCORA, INC. |
| Issuer | Morgan Stanley |
| WKN | ME2CK5 |
| ISIN | DE000ME2CK53 |
| Date issued | 20/10/2023 |
| Strike | 260 $ |
| Maturity | 21/06/2024 (23 Days) |
| Parity | 10 : 1 |
| Emission price | 0.1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.57 € |
|---|---|
| Lowest since issue | 0.001 € |
| Spread | 0.033 € |
| Spread % | 53.23% |
Company Profile
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Sector
-
Consensus: Cencora, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
216.2
USD
Average target price
255.1
USD
Spread / Average Target
+18.00%
- Stock Market
- Warrants
- Warrant
